Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.

Journal of Clinical Microbiology
Matthias ImöhlMark van der Linden

Abstract

A total of 7,764 isolates from patients with invasive pneumococcal disease (IPD) were collected from 1992 to June 2006. Data on serotypes were available for 5,022 isolates (64.7% of all invasive isolates). Some 54.0% of the isolates originated from adults >or=16 years of age, and 46.0% were from children <16 years of age. The leading serotypes were 14, 23F, 1, 6B, 7F, 3, and 4. The serotypes significantly more common in children were 14, 6B, 19F, and 18C, while among adults, serotypes 3 and 4 were predominant. Serotype 7F was statistically more prevalent among children <4 months old than among the other age groups. Among children aged >or=4 months and <1 year, serotype 19F occurred statistically more frequently; and among children aged >or=1 year to <5 years, serotypes 14, 6B, and 18C were overrepresented. The serotypes predominantly affecting patients younger than the remaining collective of patients were 14, 6B, 19F, and 18C, while patients with IPD caused by serotypes 3, 4, and 9V were older than the collective, on average.

References

Mar 1, 1981·Reviews of Infectious Diseases·R Austrian
Jun 1, 1994·Journal of Clinical Microbiology·J F PlouffeR R Facklam
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J A ScottA Taunay
Jan 3, 2001·The New England Journal of Medicine·C G WhitneyUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Apr 13, 2001·JAMA : the Journal of the American Medical Association·K A RobinsonUNKNOWN Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R Feikin, Keith P Klugman
Nov 5, 2003·Pediatrics·Jill A HoffmanSheldon L Kaplan
Nov 10, 2004·International Journal of Medical Microbiology : IJMM·Ralf René Reinert
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel R FeikinUNKNOWN Active Bacterial Core surveillance/Emerging Infections Program Network
Jul 26, 2005·Infection and Immunity·Sven HammerschmidtManfred Rohde
Nov 26, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R R ReinertD S Fedson
Nov 15, 2007·The Journal of Antimicrobial Chemotherapy·Johan FlamaingWilly E Peetermans
Jul 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rochelle LacapaKatherine L O'Brien
Jun 11, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D KellnerDavid W Scheifele
Jun 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Angelique G S C JansenEelko Hak
Aug 18, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M ImöhlM van der Linden

❮ Previous
Next ❯

Citations

Nov 5, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L SelvaC Muñoz-Almagro
Jun 22, 2012·Cardiology in the Young·Lee MorrisMichael Tosi
Jun 15, 2013·Emerging Infectious Diseases·Sandra S RichterGary V Doern
Nov 15, 2011·Expert Opinion on Biological Therapy·Robert W Frenck, Sylvia Yeh
Nov 26, 2015·Vaccine·Altynay ShigayevaUNKNOWN Toronto Invasive Bacterial Diseases Network
Sep 16, 2011·Vaccine·Gail L Rodgers, Keith P Klugman
May 18, 2010·International Journal of Antimicrobial Agents·Moses L JolobaMichael R Jacobs
Sep 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Altynay ShigayevaUNKNOWN Toronto Invasive Bacterial Diseases Network
Mar 23, 2011·International Journal of Antimicrobial Agents·Christine BleyRalf René Reinert
Nov 22, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E del AmoC Muñoz-Almagro
Aug 18, 2016·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Vicki MountEmma Best
Aug 4, 2011·Expert Review of Vaccines·David S FedsonSandrine I Samson
Aug 8, 2017·Expert Review of Vaccines·Raul IsturizLuis Jodar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.